- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04332146
Mindfulness-based Intervention for Postnatal Depression
The Impacts of Mindfulness-based Intervention on Symptoms and Cognition in Chinese Women With Postnatal Depressive Symptoms - A Randomized Controlled Clinical Trial
Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions were found to be beneficial for symptoms in perinatal and antenatal women with depression. These non-pharmacological interventions require less resources and are more feasible for postnatal women to practice at home. To date, no randomized controlled trial has examined mindfulness-based intervention program as a treatment for women with postnatal depression. The proposed randomized controlled trial aims to examine the effects of an 8-week mindfulness-based intervention program on symptom and cognition for postnatal females with depressive symptoms.
A total of 70 postnatal women with depressive symptoms will be recruited from the psychiatric outpatient clinics in Hong Kong, and will be randomized into two groups: 1) an 8-week mindfulness-based intervention program (n=35); 2) a booklet-based psychoeducation control group (n=35). All participants will be assessed for depression, anxiety, stress, cognition, role functioning, quality of life, sleep quality and mindfulness ability at the baseline, 8 weeks, and 3 months after intervention. The intervention sessions will be held once weekly lasting 90 minutes for 8 weeks.
The investigators primarily hypothesize that participants in the mindfulness-based intervention group will improve depressive symptom after 8 weeks compared with the control group. Secondary, the mindfulness-based intervention will improve anxiety, stress, cognitive functions, sleep quality, quality of life and mindfulness ability.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Jingxia Lin, PhD
- Telefonnummer: 852-39176311
- E-post: jxlin@hku.hk
Studieorter
-
-
-
Hong Kong, Hong Kong
- Rekrytering
- Queen Mary Hospital
-
Kontakt:
- Jingxia Lin, PhD
- Telefonnummer: 852-39176311
- E-post: jxlin@hku.hk
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Females aged from 18 and above
- The Edinburgh Postnatal Depression Scale cut-off score of >=9
- At least 6 weeks, and up to one and half years after childbirth
- Cantonese-speaking Chinese
Exclusion Criteria:
- Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
- Comorbid substance dependence
- Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
- Known pregnancy
- A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
- Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Mindfulness-based intervention
|
The MBI-p-R was developed in line with the model of Mindfulness-based Stress Reducation (MBSR) proposed by Kabat-Zinn.
It will be conducted for 1.5 hours for each session, once a week for 8 weeks.
There are four key operational components to be included in each session: engagement and introduction, mindfulness practices, daily life application, and consolidation of learning.
|
Aktiv komparator: Booklet-based psychoeducation group
|
The participants in the control group will be provided a booklet at baseline, including general information in handling every day stress by a new mother, as well as a record for their weekly activities.
The contents covered a range of topics including work-stress, balanced diet, physical exercise, sleeping quality, bonding with baby and the treatment for depression.
The participants will be contacted by phone call and/or whatsapp weekly for a short talk based on the record and content on the booklet.
They will also be asked to record their daily life weekly for discussion.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change from Baseline Depression at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Depression at 3 months
Tidsram: Change from 8 weeks to 3 months
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change from Baseline Anxiety at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Anxiety at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Stress at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Stress at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Executive Function at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Executive Function at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Attention at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Attention at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Working Memory at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Working Memory at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Visual-Motor Coordination at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Visual-Motor Coordination at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Role Functioning at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Role Functioning at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Quality of Life at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Quality of Life at 3 months
Tidsram: Change from 8 weeks to 3 months
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Sleep Quality at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Sleep Quality at 3 months
Tidsram: Change from 8 weeks to 3 months
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Mindfulness Levels at 8 weeks
Tidsram: Change from baseline to 8 weeks
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Mindfulness Levels at 3 months
Tidsram: Change from 8 weeks to 3 months
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Total attendant classes during the 8-week interventions
Tidsram: At 8 weeks
|
The number of classes the participants attended during the 8-week period will be recorded
|
At 8 weeks
|
Self-practice time
Tidsram: At 8 weeks
|
How much time the participants spend for self-practice at home will be recorded
|
At 8 weeks
|
Self-practice time
Tidsram: At 3 months
|
How much time the participants spend for self-practice at home will be recorded
|
At 3 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Jingxia Lin, PhD, The University of Hong Kong
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- UW17-431
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Postnatal depression
-
Lancashire Care NHS Foundation TrustUniversity of ManchesterAvslutadDepression, postpartum | Postnatal depression hos brittiska sydasiatiska kvinnorStorbritannien
-
University of CopenhagenUniversity of AarhusAktiv, inte rekryterandeSpädbarns sociala tillbakadragande | Maternal postnatal depressionDanmark
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside UniversityRekryteringPostnatal depressionStorbritannien
-
Ministry of Health, MalaysiaAvslutad
-
University of MelbourneAvslutad
-
Nottingham Trent UniversityHar inte rekryterat ännu
-
King's College LondonUniversity College, LondonHar inte rekryterat ännu
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside University; University of JosHar inte rekryterat ännu
-
Emily EisnerManchester University NHS Foundation TrustAvslutad
-
Pakistan Institute of Living and LearningAvslutad
Kliniska prövningar på Mindfulness-based program (MBI-p-R)
-
Universidad Miguel Hernandez de ElcheAvslutadNeurodegenerativa sjukdomar | Demens | Alzheimers sjukdomSpanien
-
University of HaifaAvslutadStresssyndrom, posttraumatisk | Stressrelaterad störningIsrael
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolAvslutadLätt kognitiv funktionsnedsättningSingapore
-
University Hospital, BordeauxAvslutad
-
AbbVie (prior sponsor, Abbott)AvslutadHumant immunbristvirusinfektion
-
M.D. Anderson Cancer CenterAktiv, inte rekryterandeAkut lymfoblastisk leukemi | Blast Phase Kronisk myelogen leukemi, BCR-ABL1 positiv | Återkommande akut lymfatisk leukemi | Refraktär Akut Lymfoblastisk Leukemi | Accelererad fas kronisk myelogen leukemi, BCR-ABL1 positiv | Akut myeloid leukemi med BCR-ABL1Förenta staterna